BioMérieux, a French health diagnostics company, broke ground on a new 25,000-square-foot facility in Durham Wednesday that is expected to create 44 jobs.
The company already employs 630 people at its U.S. headquarters in Durham, where it makes products for diagnosing infectious diseases and cancer screening.
This latest expansion will be the company’s fourth product line in Durham. The line will focus on making products used for the detection and identification of bloodborne infections, specifically sepsis, a severe blood infection that can lead to organ failure or death.
BioMérieux is investing more than $48 million in the new facility, which is expected to be completed by late 2016.
The company is eligible to receive a $220,000 One North Carolina Fund grant and a local match if it meets the job and investment targets. The grant was first awarded in January 2013.